| 1 | Drug Resistance Updates | 29.1 | 99th | Q1 | SCIE | – | No |
| 2 | Pharmacology and Therapeutics | 28.3 | 99th | Q1 | SCIE | – | No |
| 3 | Drugs | 25.3 | 99th | Q1 | SCIE | – | No |
| 4 | Journal of Biomedical Science | 21.4 | 98th | Q1 | SCIE | – | Yes |
| 5 | Acta Pharmacologica Sinica | 17.7 | 98th | Q1 | SCIE | – | No |
| 6 | OpenNano | 17.3 | 98th | Q1 | – | – | Yes |
| 7 | Nano TransMed | 15 | 97th | Q1 | – | – | Yes |
| 8 | American Journal of Transplantation | 14.4 | 97th | Q1 | SCIE | – | No |
| 9 | Alimentary Pharmacology and Therapeutics | 14 | 96th | Q1 | SCIE | – | No |
| 10 | BioDrugs | 13.8 | 96th | Q1 | SCIE | – | No |
| 11 | CNS Drugs | 13.7 | 96th | Q1 | SCIE | – | No |
| 12 | Chinese Herbal Medicines | 13.5 | 95th | Q1 | ESCI | – | Yes |
| 13 | European Neuropsychopharmacology | 13.2 | 95th | Q1 | SCIE | – | No |
| 14 | Neurotherapeutics | 12.6 | 95th | Q1 | SCIE | – | Yes |
| 15 | npj Breast Cancer | 12.4 | 94th | Q1 | SCIE | – | Yes |
| 16 | Medicine in Drug Discovery | 11.5 | 94th | Q1 | – | – | Yes |
| 17 | Current Neuropharmacology | 11.4 | 94th | Q1 | SCIE | – | No |
| 18 | European Heart Journal - Cardiovascular Pharmacotherapy | 11 | 93th | Q1 | SCIE | – | No |
| 19 | Journal of Psychopharmacology | 10.3 | 93th | Q1 | SCIE | – | No |
| 20 | Cancer Drug Resistance | 10.3 | 92th | Q1 | ESCI | – | No |
| 21 | Antibiotics | 10.2 | 92th | Q1 | SCIE | – | Yes |
| 22 | Cochrane Database of Systematic Reviews | 10.2 | 92th | Q1 | SCIE | – | No |
| 23 | Clinical Pharmacology and Therapeutics | 9.9 | 91th | Q1 | SCIE | – | No |
| 24 | npj Vaccines | 9.8 | 91th | Q1 | SCIE | – | Yes |
| 25 | Molecular Therapy Oncology | 9.6 | 91th | Q1 | SCIE | – | Yes |
| 26 | Frontiers in Pharmacology | 9.5 | 90th | Q1 | SCIE | – | Yes |
| 27 | Current Treatment Options in Oncology | 9.3 | 90th | Q1 | SCIE | – | No |
| 28 | Cardiovascular Drugs and Therapy | 9 | 90th | Q1 | SCIE | – | No |
| 29 | European Archives of Psychiatry and Clinical Neuroscience | 8.7 | 89th | Q1 | SCIE | – | No |
| 30 | Inflammopharmacology | 8.7 | 89th | Q1 | SCIE | – | No |
| 31 | Pharmaceutical Research | 8.7 | 89th | Q1 | SCIE | – | No |
| 32 | CNS Neuroscience and Therapeutics | 8.5 | 88th | Q1 | SCIE | – | Yes |
| 33 | Expert Opinion on Investigational Drugs | 8.5 | 88th | Q1 | SCIE | – | No |
| 34 | Antimicrobial Resistance and Infection Control | 8.4 | 87th | Q1 | SCIE | – | Yes |
| 35 | Drug Safety | 8.4 | 87th | Q1 | SCIE | – | No |
| 36 | Pharmaceutical Medicine | 8.4 | 87th | Q1 | ESCI | – | No |
| 37 | International Journal of Antimicrobial Agents | 8.3 | 86th | Q1 | SCIE | – | No |
| 38 | International Journal of Neuropsychopharmacology | 8.3 | 86th | Q1 | SCIE | – | Yes |
| 39 | Rheumatology | 8.3 | 86th | Q1 | SCIE | – | No |
| 40 | Antimicrobial Agents and Chemotherapy | 8 | 85th | Q1 | SCIE | – | No |
| 41 | PPAR Research | 7.8 | 85th | Q1 | SCIE | – | Yes |
| 42 | World Journal of Men's Health | 7.8 | 85th | Q1 | SCIE | – | Yes |
| 43 | Frontiers in Medical Technology | 7.8 | 84th | Q1 | ESCI | – | Yes |
| 44 | Vaccines | 7.7 | 84th | Q1 | SCIE | – | Yes |
| 45 | Advances in Therapy | 7.6 | 83th | Q1 | SCIE | – | No |
| 46 | Cannabis and Cannabinoid Research | 7.6 | 83th | Q1 | SCIE | – | No |
| 47 | Pharmacopsychiatry | 7.6 | 83th | Q1 | SCIE | – | No |
| 48 | Clinical Pharmacokinetics | 7.6 | 82th | Q1 | SCIE | – | No |
| 49 | ADMET and DMPK | 7.5 | 82th | Q1 | ESCI | – | Yes |
| 50 | British Journal of Clinical Pharmacology | 7.3 | 82th | Q1 | SCIE | – | No |
| 51 | Drugs and Aging | 7.2 | 81th | Q1 | SCIE | – | No |
| 52 | Pharmacotherapy | 7.2 | 81th | Q1 | SCIE | – | No |
| 53 | Primary Care - Clinics in Office Practice | 7.2 | 81th | Q1 | SCIE | – | No |
| 54 | Drug Metabolism Reviews | 7.1 | 80th | Q1 | SCIE | – | No |
| 55 | Pediatric Drugs | 7 | 80th | Q1 | SCIE | – | No |
| 56 | Therapeutic Advances in Psychopharmacology | 7 | 80th | Q1 | SCIE | – | Yes |
| 57 | Targeted Oncology | 6.9 | 79th | Q1 | SCIE | – | No |
| 58 | Journal of Psychiatry and Neuroscience | 6.7 | 79th | Q1 | SCIE, SSCI | – | No |
| 59 | Journal of Antimicrobial Chemotherapy | 6.6 | 78th | Q1 | SCIE | – | No |
| 60 | Drug and Alcohol Dependence | 6.5 | 78th | Q1 | SCIE, SSCI | – | No |
| 61 | Expert Review of Neurotherapeutics | 6.3 | 78th | Q1 | SCIE | – | No |
| 62 | Cardiovascular Therapeutics | 6.1 | 77th | Q1 | SCIE | – | Yes |
| 63 | Expert Opinion on Drug Safety | 6.1 | 77th | Q1 | SCIE | – | No |
| 64 | Therapeutic Advances in Vaccines and Immunotherapy | 6 | 77th | Q1 | – | – | Yes |
| 65 | American Journal of Cardiovascular Drugs | 6 | 76th | Q1 | SCIE | – | No |
| 66 | Chinese Journal of Integrative Medicine | 5.9 | 76th | Q1 | SCIE | – | No |
| 67 | Expert Review of Clinical Pharmacology | 5.9 | 76th | Q1 | SCIE | – | No |
| 68 | Expert Opinion on Emerging Drugs | 5.9 | 75th | Q1 | SCIE | – | No |
| 69 | Journal of Dietary Supplements | 5.9 | 75th | Q1 | ESCI | – | No |
| 70 | Pulmonary Pharmacology and Therapeutics | 5.9 | 75th | Q1 | SCIE | – | No |
| 71 | Annals of Pharmacotherapy | 5.8 | 74th | Q2 | SCIE | – | No |
| 72 | Investigational New Drugs | 5.8 | 74th | Q2 | SCIE | – | No |
| 73 | International Journal for Parasitology: Drugs and Drug Resistance | 5.8 | 73th | Q2 | SCIE | – | Yes |
| 74 | Journal of Addiction Medicine | 5.8 | 73th | Q2 | SCIE | – | No |
| 75 | Clinical Therapeutics | 5.7 | 73th | Q2 | SCIE | – | No |
| 76 | Pharmacological Research - Modern Chinese Medicine | 5.7 | 72th | Q2 | – | – | Yes |
| 77 | Advances in Pharmacological and Pharmaceutical Sciences | 5.6 | 72th | Q2 | ESCI | – | Yes |
| 78 | HIV Medicine | 5.6 | 72th | Q2 | SCIE | – | No |
| 79 | European Journal of Clinical Pharmacology | 5.6 | 71th | Q2 | SCIE | – | No |
| 80 | Fundamental and Clinical Pharmacology | 5.6 | 71th | Q2 | SCIE | – | No |
| 81 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | 71th | Q2 | SCIE | – | No |
| 82 | International Clinical Psychopharmacology | 5.6 | 70th | Q2 | SCIE | – | No |
| 83 | Journal of Cardiovascular Pharmacology and Therapeutics | 5.6 | 70th | Q2 | SCIE | – | Yes |
| 84 | Infection and Drug Resistance | 5.6 | 69th | Q2 | SCIE | – | Yes |
| 85 | Photodiagnosis and Photodynamic Therapy | 5.6 | 69th | Q2 | SCIE | – | Yes |
| 86 | Orphanet Journal of Rare Diseases | 5.5 | 69th | Q2 | SCIE | – | Yes |
| 87 | Journal of Cannabis Research | 5.5 | 68th | Q2 | ESCI | – | Yes |
| 88 | Breast Cancer | 5.4 | 68th | Q2 | SCIE | – | No |
| 89 | Therapeutic Advances in Infectious Disease | 5.3 | 68th | Q2 | ESCI | – | Yes |
| 90 | ACS Pharmacology and Translational Science | 5.2 | 67th | Q2 | ESCI | – | No |
| 91 | Vascular Health and Risk Management | 5.2 | 67th | Q2 | ESCI | – | Yes |
| 92 | Clinical Drug Investigation | 5.2 | 66th | Q2 | SCIE | – | No |
| 93 | Clinical Psychopharmacology and Neuroscience | 5.2 | 66th | Q2 | SCIE | – | No |
| 94 | Drug Metabolism and Pharmacokinetics | 5.2 | 66th | Q2 | SCIE | – | No |
| 95 | Therapeutic Advances in Respiratory Disease | 5.1 | 66th | Q2 | SCIE | – | Yes |
| 96 | CPT: Pharmacometrics and Systems Pharmacology | 5.1 | 65th | Q2 | SCIE | – | Yes |
| 97 | PharmaNutrition | 5.1 | 65th | Q2 | ESCI | – | No |
| 98 | Infection and Chemotherapy | 5.1 | 64th | Q2 | ESCI | – | Yes |
| 99 | Journal of Experimental Pharmacology | 5.1 | 64th | Q2 | – | – | Yes |
| 100 | Medical Cannabis and Cannabinoids | 5 | 64th | Q2 | – | – | Yes |